chalcone has been researched along with Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavasiri, W; Danova, A; Jutabha, P; Muanprasat, C; Noitem, R; Poolsri, W; Raveesunthornkiat, M | 1 |
| Chen, J; Chu, S; Deng, Y; Kou, X; Lee, M; Li, H; Li, Z; Liao, S; Liu, D; Liu, X; Xie, W; Zhao, H | 1 |
| Chu, J; Duan, J; Hu, N; Li, H; Liu, M; Lu, C; Sun, J; Wang, C; Wang, F; Wang, Y; Wen, A | 1 |
| OSTERMAN, FA | 1 |
4 other study(ies) available for chalcone and Kidney Diseases
| Article | Year |
|---|---|
Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis.
Topics: Animals; Antifibrotic Agents; Chalcone; Chalcones; Fibrosis; Kidney; Kidney Diseases; Mice; Renal Insufficiency, Chronic; Transforming Growth Factor beta1; Ureteral Obstruction | 2023 |
Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
Topics: Animals; Apoptosis; Chalcone; Diabetes Mellitus, Experimental; Kidney Diseases; Male; Oxidative Stress; Quinones; Rats; Rats, Wistar | 2020 |
Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Cell Proliferation; Chalcone; Creatinine; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Quinones; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction | 2016 |
Hesperidin-methylene-carboxy-chalcone in chronic kidney diseases.
Topics: Chalcone; Flavones; Hesperidin; Humans; Kidney Diseases; Methane; Renal Insufficiency, Chronic | 1957 |